Literature DB >> 16396498

Analysis of total N-glycans in cell membrane fractions of cancer cells using a combination of serotonin affinity chromatography and normal phase chromatography.

Ryosuke Naka1, Satoru Kamoda, Aya Ishizuka, Mitsuhiro Kinoshita, Kazuaki Kakehi.   

Abstract

Cell surface glycans and recognition molecules of these glycans play important roles in cellular recognition and trafficking, such as in the inflammation response by sialyl LewisX oligosaccharides. Malignant cells also utilize a similar mechanism during colonization and establishment of tumor tissues in the host. These considerations prompt us to develop a screening method for comprehensive analysis of N-glycans derived from membrane fractions of cancer cells. The method involves two step separations. Initially, N-glycans released from cell membrane fractions with N-glycoamidase F were labeled with 2-aminobenzoic acid and separated based on the number of sialic acid residues attached to the oligosaccharides using affinity chromatography on a serotonin-immobilized stationary phase. Each of the nonretarded fractions containing asialo- and high-mannose type oligosaccharides and mono-, di-, tri-, and tetra-sialooligosaccharide fractions which were desialylated with neuraminidase was analyzed by a combination of HPLC using an Amide-80 column as the stationary phase and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). We analyzed total N-glycan pools of membrane fractions obtained from some cancer cells, and found that U937 cells (Histocytic lymphoma cells) expressed a large amount of oligosaccharides having polylactosamine residues and MKN45 cells (Gastric adenocarcinoma cells) contained hyper-fucosylated oligosaccharides which contained multiple fucose residues. The method described here will be a powerful technique for glycomics studies in cell surface glycoproteins, and will enable one to search marker oligosaccharides characteristically observed in various diseases such as cancer, inflammation, and congenital disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16396498     DOI: 10.1021/pr0502976

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  9 in total

1.  A ratiometric lectin microarray approach to analysis of the dynamic mammalian glycome.

Authors:  Kanoelani T Pilobello; Deepika E Slawek; Lara K Mahal
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-02       Impact factor: 11.205

2.  Targeted glycomics by selected reaction monitoring for highly sensitive glycan compositional analysis.

Authors:  Hongquan Zhang; Zhaohui Wang; Jacek Stupak; Othman Ghribi; Jonathan D Geiger; Qing Yan Liu; Jianjun Li
Journal:  Proteomics       Date:  2012-07-23       Impact factor: 3.984

3.  Activity of lysosomal exoglycosidases in human gliomas.

Authors:  P Wielgat; U Walczuk; S Szajda; M Bień; L Zimnoch; Z Mariak; K Zwierz
Journal:  J Neurooncol       Date:  2006-05-19       Impact factor: 4.130

4.  Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery.

Authors:  William R Alley; Milan Madera; Yehia Mechref; Milos V Novotny
Journal:  Anal Chem       Date:  2010-06-15       Impact factor: 6.986

Review 5.  Solid-phase glycan isolation for glycomics analysis.

Authors:  Shuang Yang; Hui Zhang
Journal:  Proteomics Clin Appl       Date:  2012-12       Impact factor: 3.494

6.  Analysis of protein glycosylation and phosphorylation using liquid phase separation, protein microarray technology, and mass spectrometry.

Authors:  Jia Zhao; Tasneem H Patwa; Manoj Pal; Weilian Qiu; David M Lubman
Journal:  Methods Mol Biol       Date:  2009

7.  Differentiation of cancer cell origin and molecular subtype by plasma membrane N-glycan profiling.

Authors:  Serenus Hua; Mary Saunders; Lauren M Dimapasoc; Seung Hyup Jeong; Bum Jin Kim; Suhee Kim; Minkyung So; Kwang-Sik Lee; Jae Han Kim; Kit S Lam; Carlito B Lebrilla; Hyun Joo An
Journal:  J Proteome Res       Date:  2014-01-08       Impact factor: 4.466

8.  High expression of β3GnT8 is associated with the metastatic potential of human glioma.

Authors:  Jun Liu; Li Shen; Lingyan Yang; Shuijun Hu; Lan Xu; Shiliang Wu
Journal:  Int J Mol Med       Date:  2014-04-08       Impact factor: 4.101

9.  Development of antimetastatic drugs by targeting tumor sialic acids.

Authors:  Da-Yong Lu; Ting-Ren Lu; Hong-Ying Wu
Journal:  Sci Pharm       Date:  2012-06-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.